DJIA 17,061.45 -37.00 -0.22%
NASDAQ 4,589.63 9.36 0.20%
S&P 500 1,998.30 -5.07 -0.25%
market minute promo

Gilead Sciences (NASDAQ: GILD)

109.08 1.52 (1.41%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GILD $109.08 1.41%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $108.17
Previous Close $107.56
Daily Range $107.61 - $109.50
52-Week Range $58.81 - $109.50
Market Cap $164.9B
P/E Ratio 24.23
Dividend (Yield) $0.00 (0.0%)
Volume 6,639,606
Average Daily Volume 13,437,229
Current FY EPS $7.26





Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website:

News & Commentary

3 Simple Ways to Invest Like George Soros

George Soros is one of the most successful investors of all time. Here are three easy ways to follow in his footsteps.

Ambit Biosciences (AMBI) Jumps: Stock Up 6.6% - Tale of the Tape

Biotechnology, Oil And Brazil ETFs To Watch This Week

Gilead Sciences Is Not Done Running

3 Stocks Reiterated As A Buy: BMY, VZ, GILD

PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for September 03, 2014

Mike Khouw's Gilead Sciences Trade

Regeneron Pharmaceuticals' Pipeline Progress Raises Costs - Analyst Blog

Regeneron Pharmaceuticals' Pipeline Progress Raises Costs - Analyst Blog

Pfizer's C. Difficile Vaccine Gets Fast Track Status - Analyst Blog

What You Need to Know About the Roche-InterMune Deal

See More GILD News...

GILD's Top Competitors

GILD $109.08 (1.41%)
Current stock: GILD
AMGN $137.61 (-1.27%)
Current stock: AMGN
CELG $95.06 (0.04%)
Current stock: CELG
$0.00 (0.00%)
Current stock: